Want to see FR:ALSPW full AI Analyst Report?
Spineway SA (ALSPW) Stock Price & Analysis
ALSPW Stock Chart & Stats
- Day’s Range
- EUR 0.09 - EUR 0.11
- 52-Week Range
- EUR 0.08 - EUR 0.21
- Previous Close
- EUR 0.09
- Volume
- N/A
- Average Volume (3M)
- 141.71K
- Market Cap
- EUR 3.23M
- Enterprise Value
- EUR 3.44M
- Total Cash (Recent Filing)
- EUR 3.50M
- Total Debt (Recent Filing)
- EUR 1.53M
- Price to Earnings (P/E)
- ―
- Beta
- 0.26
- Next Earnings
- Jan 25, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin Recovery
Steady multi-year revenue growth and a materially recovered gross margin indicate improving commercial traction and operating economics. If maintained, this progress can strengthen the company’s ability to scale its spinal implant platform and move closer to sustainable profitability over the next several quarters.
Improved Operating Cash Flow
The return to positive operating cash flow is an important improvement in the underlying business model, showing that operations generated cash before investment spending. Sustaining this trend would reduce reliance on external funding and provide greater flexibility to support commercial development.
Conservative Leverage
Very low leverage gives Spineway a comparatively resilient financial structure while it works toward profitability. Limited debt obligations should reduce refinancing and interest burdens, preserve strategic flexibility, and improve the company’s ability to withstand periods of uneven procedure demand.
Bears Say
Persistent Loss-Making Operations
Despite revenue and gross-margin improvement, Spineway has not yet converted its business into sustainable earnings. Persistent operating and net losses can consume capital, limit internally funded investment, and make future growth more dependent on continued financial support.
Weak Free Cash Flow Generation
Operating cash flow has improved, but the absence of positive free cash flow shows that investment needs still absorb the cash generated by operations. Until free cash generation becomes consistently positive, financial flexibility remains constrained and funding execution risk stays elevated.
Negative Return On Equity
Negative return on equity indicates that the company’s substantial equity base is not yet producing an economic return. This weakens capital efficiency and signals that revenue expansion and margin recovery have not progressed far enough to reward shareholders through profitable utilization of invested capital.
Spineway SA News
ALSPW FAQ
What was Spineway SA’s price range in the past 12 months?
What is Spineway SA’s market cap?
When is Spineway SA’s upcoming earnings report date?
How were Spineway SA’s earnings last quarter?
Is Spineway SA overvalued?
Does Spineway SA pay dividends?
What is Spineway SA’s EPS estimate?
How many shares outstanding does Spineway SA have?
What happened to Spineway SA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Spineway SA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Spineway SA
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Stéphane Le Roux
- Employees
- 43
- Website
- www.spineway.com
- Address
- 7, allEe Moulin Berger, Ecully, AR, 69130, FR
Spineway SA (ALSPW) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 6 | 12 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 2 | 0 | 10 |


